Company News

<div class="articleWrapper"><div class="articleContent"><h1 class="text title">China guidelines point to HIV protease inhibitors as potential coronavirus treatment</h1><div class="byline">Hongjiang Li, Staff Writer</div><div class="date">January 30, 2020 2:04 AM GMT</div><div class="date">Updated on Mar 26, 2020 at 12:58 AM GMT</div></div></div>

AbbVie Inc.

Ascletis Pharmaceuticals Co. Ltd.

cov19count

Kaletra, lopinavir/ritonavir (ABT-378/r)

China guidelines point to HIV protease inhibitors as potential coronavirus treatment

Featured Analysis

Articles

Current Editions

Data Graphics

Podcasts & Webcasts

Special Reports & Presentations

White Papers

Analysis

BCIQ

Company Profiles

Product Profiles

Target Profiles

Financial Dashboards

BCIQ Data

All Events

China Healthcare Summit

Bio€quity Europe

Events

My Workspace

Company Overview

Management

Editorial & Research Team

Scientific Advisory Board

About BioCentury

Contact Us

Forgot Password

Trial

Subscribe

Advertising & Sponsorship

Career Opportunities

Customer Resource Center

Contact

Home